Cargando…
Prenatal Use of Sildenafil in Fetal Growth Restriction and Its Effect on Neonatal Tissue Oxygenation—A Retrospective Analysis of Hemodynamic Data From Participants of the Dutch STRIDER Trial
Objective: Sildenafil is under investigation as a potential agent to improve uteroplacental perfusion in fetal growth restriction (FGR). However, the STRIDER RCT was halted after interim analysis due to futility and higher rates of persistent pulmonary hypertension and mortality in sildenafil-expose...
Autores principales: | Terstappen, Fieke, Richter, Anne E., Lely, A. Titia, Hoebeek, Freek E., Elvan-Taspinar, Ayten, Bos, Arend F., Ganzevoort, Wessel, Pels, Anouk, Lemmers, Petra M., Kooi, Elisabeth M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744464/ https://www.ncbi.nlm.nih.gov/pubmed/33344386 http://dx.doi.org/10.3389/fped.2020.595693 |
Ejemplares similares
-
Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction
por: Pels, Anouk, et al.
Publicado: (2019) -
Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER study
por: Pels, Anouk, et al.
Publicado: (2022) -
Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial
por: Pels, Anouk, et al.
Publicado: (2020) -
Long-term renal disease after prematurity or fetal growth restriction: who is at risk?
por: Terstappen, Fieke, et al.
Publicado: (2020) -
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials
por: Pels, A., et al.
Publicado: (2017)